NDC 48433-314-01 - Furosemide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 48433-314
- Requested NDC
- 48433-314-01
- Package NDCs from labels
- 48433-314-01, 48433-314-10
- Manufacturer
- Safecor Health, LLC
- Effective date
- 2012-06-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Furosemide - Safecor Health, LLC | Safecor Health, LLC | 2012-06-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FUROSEMIDE | ACTIVE INGREDIENT | 7LXU5N7ZO5 | FUROSEMIDE TABLET [SAFECOR HEALTH, LLC] | 1 | |
| FUROSEMIDE | ACTIVE MOIETY | 7LXU5N7ZO5 | FUROSEMIDE TABLET [SAFECOR HEALTH, LLC] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | FUROSEMIDE TABLET [SAFECOR HEALTH, LLC] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | FUROSEMIDE TABLET [SAFECOR HEALTH, LLC] | 1 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | FUROSEMIDE TABLET [SAFECOR HEALTH, LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Furosemide | FUROSEMIDE | REMEDYREPACK INC. | dba00759-87b4-4ecf-998e-ba03ed3d2f1a | 2026-08-17 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Redpharm Drug | 58d2a38d-75f8-dcb9-e063-6294a90a10d7 | 2026-08-12 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Medical Purchasing Solutions, LLC | 58cc1e38-6000-1489-e063-6394a90a5978 | 2026-08-11 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| FUROSCIX | FUROSEMIDE INJECTION 80 MG/ 10 ML | scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation | eac958dd-8d43-e44e-e053-2995a90a4d5e | 2026-07-31 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | REMEDYREPACK INC. | 7cdcd001-ab4b-4210-a455-2e17a7bc4972 | 2026-07-24 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | REMEDYREPACK INC. | 3d312ab0-589c-427b-84da-18887244bfc9 | 2026-07-15 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | St. Mary's Medical Park Pharmacy | febeaf8c-0f4b-cc40-e053-6394a90a873e | 2026-06-30 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | REMEDYREPACK INC. | 916de29e-228c-4dfc-bcee-ad9a641316bd | 2026-06-24 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | REMEDYREPACK INC. | e8c27f1c-dc81-44b1-8663-a7d663bad89f | 2026-06-23 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Atlantic Biologicals Corp. | 54ed0dd9-2fa8-269a-e063-6294a90a607c | 2026-06-23 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | HF Acquisition Co LLC, DBA HealthFirst | 75d5611a-f9e0-1841-e053-2991aa0af415 | 2026-06-23 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Unit Dose Solutions, Inc. | 54dd664a-c7ec-27f3-e063-6294a90aff9f | 2026-06-22 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Cardinal Health 107, LLC | 2a5bcf50-6d63-463a-915e-a72ea2e5f131 | 2026-06-18 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Granulation Technology, Inc. | 462e8917-cbe0-f4f9-e063-6394a90ab4ff | 2026-06-17 | Warnings, Adverse reactions | NDA018569 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Atlantic Biologicals Corps | 9c342198-7162-4cc5-bda1-bc4054a4292b | 2026-06-16 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Coupler LLC | 53e58232-f7f9-c09b-e063-6394a90a5bc4 | 2026-06-10 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Cardinal Health 107, LLC | 42478c55-9056-487a-89a9-d36904beea12 | 2026-06-02 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Major Pharmaceuticals | 6be1addd-a811-47fc-8650-6870d661c234 | 2026-05-26 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Cardinal Health 107, LLC | 71b48f4d-9936-448c-9e3a-33f1182e1039 | 2026-05-15 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Hospira, Inc. | 39fd32f2-6bb7-4a65-d298-e48d26bc80c7 | 2026-05-13 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.